CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,064,408 | +28.3% | 75,772 | +4.8% | 0.05% | +23.8% |
Q2 2023 | $1,608,475 | +19.9% | 72,291 | +9.5% | 0.04% | +10.5% |
Q4 2022 | $1,341,394 | +205.6% | 66,046 | +285.6% | 0.04% | +153.3% |
Q3 2022 | $439,000 | -67.7% | 17,129 | -70.0% | 0.02% | -75.4% |
Q2 2022 | $1,358,000 | +10.8% | 57,105 | +4.9% | 0.06% | +5.2% |
Q1 2022 | $1,226,000 | +26.3% | 54,447 | +11.0% | 0.06% | -3.3% |
Q4 2021 | $971,000 | +302.9% | 49,065 | +301.1% | 0.06% | +215.8% |
Q3 2021 | $241,000 | -77.6% | 12,232 | -80.2% | 0.02% | -72.5% |
Q3 2020 | $1,077,000 | +144.8% | 61,875 | +136.8% | 0.07% | +122.6% |
Q2 2020 | $440,000 | +214.3% | 26,130 | +125.1% | 0.03% | +287.5% |
Q4 2019 | $140,000 | -82.5% | 11,608 | -80.6% | 0.01% | -84.0% |
Q4 2018 | $800,000 | +288.3% | 59,868 | +308.0% | 0.05% | +233.3% |
Q3 2018 | $206,000 | -30.2% | 14,672 | -21.9% | 0.02% | -25.0% |
Q2 2018 | $295,000 | -59.0% | 18,789 | -57.0% | 0.02% | -60.0% |
Q1 2018 | $719,000 | +255.9% | 43,688 | +137.4% | 0.05% | +92.3% |
Q1 2017 | $202,000 | – | 18,400 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |